Organization
Wakayama Medical University, Wakayama, Japan
7 abstracts
2 posters
Abstract
A phase 2 trial of CHOP with anti-CCR4 antibody mogamulizumab for elderly patients with CCR4-positive adult T-cell leukemia/lymphoma.Org: National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan, Nagoya City University Graduate School of Medical Sciences, Imamura General Hospital, Kumamoto University Hospital, Kindai University Faculty of Medicine, Osaka-Sayama, Japan,
Abstract
The primary endpoint analysis of SCARLET study: A single-arm, phase II study of sotorasib plus carboplatin-pemetrexed in patients with advanced non-squamous, non-small cell lung cancer with KRAS G12C mutation (WJOG14821L).Org: Kumamoto University Hospital, Kurume University School of Medicine, Kitakyushu Municipal Medical Center, Wakayama Medical University, Wakayama, Japan, Internal Medicine III, Wakayama Medical University,
Abstract
Subcutaneous amivantamab vs intravenous amivantamab, both in combination with lazertinib, in refractory EGFR-mutated, advanced non-small cell lung cancer (NSCLC): Primary results, including overall survival (OS), from the global, phase 3, randomized controlled PALOMA-3 trial.Org: Princess Margaret Cancer Centre, Wakayama Medical University, Wakayama, Japan, Division of Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, Jilin Cancer Hospital, Drug Development Unit, The Royal Marsden Hospital and The Institute of Cancer Research,
Abstract
Radiation therapy (RT)-free pembrolizumab plus chemotherapy (P+C) for PD-L1 TPS ≥50% locally advanced non-small cell lung cancer (LA-NSCLC): An early report analyzing depth of response from multicenter single arm phase II study (Evolution trial: WJOG11819L).Org: Kobe Minimally Invasive Cancer Center, National Hospital Organization Nagoya Medical Center, Aichi, Japan, Takarazuka City Hospital, Hyogo Medical University, Kurashiki Central Hospital, Kurashiki, Japan,
Abstract
First report of ELUCIDATOR study: A prospective observational multicenter study on resistance mechanisms in patients with early disease progression during osimertinib.Org: National Hospital Organization Himeji Medical Center, National Hospital Organization Kinki-Chuo Chest Medical Center, Center for Biomedical Sciences, Wakayama Medical University, Wakayama, Japan, Wakayama Medical University, Wakayama, Japan, National Hospital Organization Asahikawa Medical Center,
Abstract
Real-world efficacy of chemotherapy in patients with advanced extramammary Paget's disease: A retrospective, multicenter study of 204 Japanese patients.Org: Kumamoto University Hospital, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan, Nagoya City University Graduate School of Medical Sciences, National Cancer Center Hospital East, Kashiwa, Japan, Graduate School of Medicine, Chiba University,
Abstract
ABATACEPT (CTLA4-IG) SUPPRESSES T CELL ACTIVATION AND REDUCES TH17 CELLS AS WELL AS PLASMA IL-6 IN PATIENTS WITH RHEUMATOID ARTHRITIS Org: Wakayama Medical University, Wakayama, Japan, Hyogo College of Medicine, Division of Rheumatology, Department of Internal Medicine, Nishinomiya, Japan, Graduate School of Medicine Kyoto University, Yukioka Hospital, NTT West Osaka Hospital, Osaka,